GlassScriptPhysician profile
Andrew Obermeier
NPI 1356457121
$4,718.53
in general payments reported to CMS, 2019-2025
24 companies · $811 in 2025
The $811 reported for 2025 was more than what 86% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $763 · 2022: $617 · 2023: $1,261 · 2024: $1,267 · 2025: $811.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,318 · Education: $19.62.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,318.46 |
| Education | $19.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $758.64 | 2021-2025 | Jot Dx, Aveir, Tendril |
| Merck Sharp & Dohme LLC | $452.36 | 2021-2025 | Verquvo |
| Novartis Pharmaceuticals Corporation | $358.34 | 2021-2025 | |
| E.R. Squibb & Sons, L.L.C. | $324.52 | 2023-2025 | Camzyos, Eliquis |
| Boston Scientific Corporation | $270.36 | 2023-2025 | Watchman Flx, Lux-Dx Insertable Cardiac Monitor, Watchman Access System |
| Amgen INC. | $265.01 | 2021-2025 | Repatha, Repatha |
| Astrazeneca Pharmaceuticals LP | $252.40 | 2021-2025 | Farxiga |
| Pfizer INC. | $242.82 | 2021-2025 | |
| Janssen Pharmaceuticals, INC | $232.90 | 2021-2024 | Xarelto |
| Bayer Healthcare Pharmaceuticals INC. | $230.06 | 2023-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $209.06 | 2021-2025 | Jardiance |
| Philips North America LLC | $199.93 | 2022-2025 | (5091) Amb Mon & Diag Und, Diagnostic Ecg Service, Extended Holter |
| Intuitive Surgical, INC. | $185.23 | 2023 | |
| Esperion Therapeutics, INC. | $160.09 | 2023-2025 | Nexletol |
| Astellas Pharma US INC | $107.42 | 2021 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $106.01 | 2021-2022 | |
| Scpharmaceuticals INC. | $73.04 | 2024-2025 | |
| Sanofi-Aventis U.S. LLC | $68.48 | 2021-2022 | |
| Alnylam Pharmaceuticals INC. | $63.02 | 2023-2025 | Onpattro |
| Gilead Sciences, INC. | $49.50 | 2021 | |
| Cvrx, INC. | $42.68 | 2025 | Barostim Neo System |
| Kestra Medical Technology Services, INC. | $28.88 | 2023 | Assure Wcd |
| Medtronic, INC. | $21.22 | 2021 | |
| Kiniksa Pharmaceuticals, LTD. | $16.56 | 2023 | Arcalyst |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Obermeier listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.